RecruitingNot ApplicableNCT07205471

Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients

The Clinical Efficacy of Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients


Sponsor

Northern Jiangsu People's Hospital

Enrollment

30 participants

Start Date

Sep 24, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In this study,the researchers compared the changes in immune function-related indicators in patients with liver cirrhosis following laparoscopic partial splenectomy,to determine whether this surgical intervention can enhance postoperative immune function and thereby improve patient outcomes.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
  • Splenomegaly with secondary hypersplenism
  • gastroesophageal variceal bleeding
  • Informed consent to participate in the study

Exclusion Criteria7

  • Hepatocellular carcinoma or any other malignancy,
  • Child-Pugh grade C
  • Recent peptic ulcer disease
  • History of Hemorrhagic stroke
  • Pregnancy.
  • Uncontrolled Hypertension
  • Human immunodeficiency virus (HIV) infection

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELaparoscopic Partial Splenectomy

The laparoscopic partial splenectomy technique involved preserving the short gastric vessels and the splenic suspensory ligament, with resection conducted along the demarcation line.


Locations(1)

Clinical Medical College of Yangzhou University

Yangzhou, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07205471


Related Trials